From nature to market: Examples of natural products that became drugs

Recent Patents on Biotechnology

Volumn 8, Issue 1, 2014, Pages 76-88

  de Fátima, Ângelo ^a   Terra, Bruna Silva ^a   da Silva, Cleiton Moreira ^a   da Silva, Daniel Leite ^a   Araujo, Debora Pereira ^a   Neto, Leonardo da Silva ^a   de Aquino, Anderson Nascimento ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Drugs; Galanthamine; Morphine; Natural products; Paclitaxel; Podophyllotoxin

Indexed keywords

BIOTECHNOLOGY; DRUG PRODUCTS;

DRUG; GALANTHAMINE; MORPHINE; NATURAL PRODUCTS; NEW SOURCES; PACLITAXEL; PODOPHYLLOTOXIN; SOURCES OF ENERGY; SOURCES OF INSPIRATIONS; TOTAL SYNTHESIS;

SYNTHESIS (CHEMICAL);

ETOPOSIDE; GALANTAMINE; MORPHINE; NATURAL PRODUCT; PACLITAXEL; PODOPHYLLOTOXIN; BIOLOGICAL PRODUCT; DRUG;

ARTICLE; CELL CYCLE ASSAY; CHEMICAL STRUCTURE; DRUG INDUSTRY; DRUG SYNTHESIS; DYNAMICS; MARKET; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAPAVER; PRIORITY JOURNAL;

BIOLOGICAL PRODUCTS; GALANTAMINE; MORPHINE; PACLITAXEL; PHARMACEUTICAL PREPARATIONS; PODOPHYLLOTOXIN;

EID: 84920106400     PISSN: 18722083     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872208307666131220163108     Document Type: Article

References (77)

1. Lachance H, Wetzel S, Kumar K, Waldmann H. Charting, navigating, and populating natural products chemical space for drug discovery. J Nat Prod 2012; 55: 5989-6001.
2. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012; 75: 311-35.
3. De Fátima A, Modolo LV, Conegero LS, et al. Styryl lactones and their derivatives: biological activities, mechanisms of action and potential leads for drug design. Curr Med Chem 2006; 13: 3371-84.
4. 7-24and finale. Org Process Res Dev 2004; 8: 122-30.
5. Mayer AMS, Glaser KB, Cuevas C, et al. The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci 2010; 31: 255-65.
6. Mendoza A, Ishihara Y, Baran PS. Scalable enantioselective total synthesis of taxanes. Nat Chem 2012; 4: 21-5.
7. Su S, Rodrigues RA, Baran PS. Scalable, stereocontrolled total synthesis of (±)-axinellamines A and B. J Am Chem Soc 2011; 133: 13922-5.
8. Shi J, Manolikakes G, Yeh CH, et al. Scalable synthesis of cortistatin A and related structures. J Am Chem Soc 2011; 133: 8014-27.
9. Burns NZ, Krylova IN, Hannoush RN, Baran PS. Scalable total synthesis and biological evaluation of haouamine A and its atropoisomer. J Am Chem Soc 2009; 131: 9172-3.
10. Nicolaou KC, Sorensen EJ. Classics in total synthesis: targets, strategies, methods. VCH: New York, 1996.
11. Nicolaou KC, Snyder SA. Classics in total synthesis II: more targets, strategies, methods. Wiley & Sons: New York, 2003.
12. Heinrich M, Teoh HL. Galanthamine from snowdrop-the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. J Ethnopharmacol 2004; 92: 147-62.
13. Wilson CR, Sauer JM, Hooser SB. Taxines: a review of the mechanism and toxicity of yew (Taxus ssp.) alkaloids. Toxicon 2001; 39: 175-85.
14. Maqbool M. Mayapple: a review of the literature from a horticultural perspective. J Med Plants Res 2011; 5: 1037-45.
15. Bohlin L, Rosén B. Podophyllotoxin derivatives: drug discovery and development. DDT 1996; 1: 343-51.
16. Calixto JB, Beirith A, Ferreira J, Santos ARS, Filho VC, Yunes RA. Naturally occuring antinociceptive substances from plants. Phytother Res 2000; 14: 401-18.
17. Gabetta B, Mercalli E. Process for the preparation of galanthamine hydrobromide. US8013151B2, 2011.
18. Lilienfeld S. Galantamine-a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. CNS Drug Rev 2002; 8: 159-76.
19. Davis B, Joullie MM. Galanthamine derivatives for treatment of Alzheimer disease. US6319919 B1, 2001.
20. Franklin R, Galding BT, Tyson RG. Galantamine amino acid and peptide prodrugs and uses thereof. US20120184532A1, 2012.
21. Satcharoen V, McLean NJ, Kemp SC, Camp NP, Brown RCD. Stereocontrolled synthesis of (-)-galanthamine. Org Lett 2007; 9: 1867-9.
22. Shimizu K, Tomioka K, Yamada SI, Koga K. Stereochemical studies. LIV. A biogenetic-type asymmetric synthesis of optically active galanthamine from L-tyrosine. Chem Pharm Bull 1978; 26: 3765-71.
23. Barton DHR, Kirby GW. Phenol ocidation and biosynthesis. Part V. The synthesis of galanthamine. J Chem Soc 1962; 806-17.
24. Chang JH, Kang HU, Jung IH, Cho CG. Total synthesis of ([)-galanthamine via C3-selective Stille coupling and IMDA cycloaddition cascade of 3, 5-dibromo-2-pyrone. Org Lett 2010; 12: 2016-8.
25. Hu XD, Tu YQ, Zhang E, et al. Total synthesis of (.)-galanthamine. Org Lett 2006; 8: 1823-5.
26. Tanimoto H, Kato T, Chida N. Total synthesis of (+)-galanthamine starting from D-glucose. Tetrahedron Lett 2007; 48: 6267-70.
27. Thal C, Guillou C, Beunard JL, Gras E, Potier P. Total synthesis of galanthamine analogues and derivatives thereof. RE41366, 2010.
28. Trost BM, Tang W. An efficient enantioselective synthesis of (-)-galanthamine. Angew Chem Int Ed 2002; 41: 2795-7.
29. Trost BM, Toste FD. Enantioselective total synthesis of (-)-galanthamine. J Am Chem Soc 2000; 122: 11262-3.
30. Chen JQ, Xie JH, Bao DH, Liu S, Zhou QL. Total synthesis of (-)-galanthamine and (-)-lycoramine via catalytic asymmetric hydrogenation and intramolecular reductive Heck cyclization. Org Lett 2012; 14: 2714-7.
31. Kodama S, Hamashima Y, Nishide K, Node M. Total synthesis of (-)-galanthamine by remote asymmetric induction. Angew Chem Int Ed 2004; 43: 2659-61.
32. Sertüner FW. Trommsdorff's. J Pharmazie 1805; 13: 234.
33. Kametani T. The Chemistry of the Isoquinoline Alkaloids. Elsevier, 1969.
34. Rinner U, Hudlicky T. Synthesis of Morphine Alkaloids and Derivatives. Top Curr Chem 2012; 309: 33-66.
35. Gates M, Tschudi G. The Synthesis of Morphine. J Am Chem Soc 1952; 78: 1380-93.
36. Taber DF, Neubert TD, Rheingold AL. Synthesis of (-)-morphine. J Am Chem Soc 2002; 124: 12416-7.
37. Parsons PJ, Penkett CS, Shell AJ. Tandem Reacions in Organic Synthesis: Novel Strategies for Natural Product Elaboration and the Development of New Synthetic Methodology. Chem Rev 1996; 96: 195-206.
38. White JD, Hrnciar P, Stappenbeck F. Asymmetric Synthesis of (+)-Morphine. The Phenanthrene Route Revisited. J Org Chem 1997; 62: 5250-1.
39. Uchida K, Yokoshima S, Kan T, Fukuyama T. Total synthesis of (±)-morphine. Org Lett 2006; 8: 5311-3.
40. Koizumi H, Yokoshima S, Fukuyama T. Total synthesis of (-)-morphine. Chem Asian J 2010; 5: 2192-8.
41. Rice KC, Iijima I. Studies in the (+)-morphinan Series I. An alternate conversion of (+)-dihydrocodeinone into (+)-codeine. Heterocycles 1977; 6: 1157-65.
42. Rice KC. A Rapid, high-yield Conversion of Codeine to Morphine. J Med Chem 1977; 20: 164-5.
43. Rice KC. Synthetic Opium Alkaloids and Derivatives. A Short Total Synthesis of (±)-Dihydrothebainone, (±)-Dihydrocodeinone, and (±)-Nordihydrocodeinone as an Approach to a Practical Synthesis of Morphine, Codeine, and Congeners. J Org Chem 1980; 45: 3135-7.
44. Magnus PD, Fauber BP, Sane N. Efficient Synthesis of morphine and codeine. US 2010/0292475 A1, 2010.
45. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 1971; 93: 2325-7.
46. De Souza MVN. Novos produtos naturais capazes de atuar na estabilização de microtúbulos, um importante alvo no combate ao câncer. Quim Nova 2004; 27: 308-12.
47. Walji AM, MacMillan DWC. Strategies to bypass the Taxol problem. Enantioselective cascade catalysis, a new approach for the efficient construction of molecular complexity. Synlett 2007; 10: 1477-89.
48. Mukaiyama T, Shiina I, Iwadare H, et al. Asymmetric Total Synthesis of Taxol. Chem Eur J 1999; 5: 121-61.
49. Corrêa AG. Taxol: Da descoberta ao uso terapêutico. Quim Nova 1995; 18: 460-7.
50. Holton RA, Kim H, Somoza C, et al. First total synthesis of Taxol. 2. Completion of the C and D rings. J Am Chem Soc 1994; 116: 1599-1600.
51. Nicolaou KC, Ueno H, Liu JJ, et al. Total synthesis of Taxol. 4. The final stages and completion of the synthesis. J Am Chem Soc 1995; 117: 653-9.
52. Danishefsky SJ, Masters JJ, Young WB, et al. Total synthesis of Baccatin III and Taxol. J Am Chem Soc 1996; 118: 2843-59.
53. Wender PA, Badham NF, Conway SP, et al. The pinene path to Taxanes. 6. A concise stereocontrolled synthesis of Taxol. J Am Chem Soc 1997; 119: 2757-8.
54. Morihira K, Hara R, Kawahara S, et al. Enantioselective total synthesis of Taxol. J Am Chem Soc 1998; 120: 12980-1.
55. Holton RA, Kim H, Somoza C, et al. First total synthesis of Taxol. 1. Functionalization of the B ring. J Am Chem Soc 1994; 116: 1597-8.
56. Holton RA, Juo RR, Kim HB, et al. A Synthesis of Taxusin. J Am Chem Soc 1998; 110: 6558-60.
57. Magnus PD. Short synthetic route to taxol and taxol derivatives. US005508447A, 1996.
58. Sisti NJ, Swindell CS, Chander MC. Paclitaxel synthesis from precursor compounds and methods of producing the same. US005948919A, 1999.
59. Swindell CS, Krauss N. Synthesis of taxol, taxol analogs and their intermediates with variable A-ring side chain structures and compositions thereof. US006072060A, 2000.
60. Vemishetti P, Gibson FS, Dillon JL. Semi-synthesis of paclitaxel using dialkyldichlorosilanes. US006242614B1, 2001.
61. Nicolaou KC, Nantermet PG, Ueno H, Guy RK, Couladouros EA, Sorensen EJ. Total synthesis of Taxol. 1. Retrosynthesis, degradation, and reconstitution. J Am Chem Soc 1995; 117: 624-33.
62. Schrecker AW, Greenberg GY, Hartwell JL. Components of podophyllin. XVI. Podophyllotoxin haloacetates and quaternary derivatives. J Am Chem Soc 1954; 76: 1184-5.
63. Ward RS. Lignans, neolignans and related compounds. Nat Prod Rep 1999; 16: 75-96.
64. Damayanthi Y, Lown JW. Podophylltoxins: Current status and recent developments. Curr Med Chem 1998; 5: 205-52.
65. Ravelli RBG, Gigant B, Curmi PA, et al. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain, Nature 2004; 428: 198-202.
66. Wu CC, Li TK, Farh L, et al. Structural Basis of Type II Topoisomerase Inhibition by the Anticancern Drug Etoposide. Science 2011; 333: 459-62.
67. Wu Y, Zhao J, Chen J, Pan C, Li L, Zhang H. Enantioselective Sequential Conjugate Addition-Allylation Reactions: A Concise Total Synthesis of (+)-Podophyllotoxin. Org Lett 2009; 11(3): 597-600.
68. Gensler WJ, Gatsonis CD. Synthesis of Podophyllotoxin, J Org Chem 1966; 31: 4004-8.
69. Andrews RC, Teague SJ, Meyers AI. Asymmetric Total Synthesis of (-)-Podophyllotoxin. J Am Chem Soc 1988; 110: 7854-8.
70. Berkowitz DB, Choi S, Maeng JH. Enzyme-Assisted Asymmetric Total Synthesis of (-)-Podophyllotoxin and (-)-Picropodophyllin. J Org Chem 2000; 65: 847-60.
71. Reynolds AJ, Scott AJ, Turner CI, Sherburn MS. The Intramolecular Carboxyarylation Approach to Podophyllotoxin. J Am Chem Soc 2003; 125: 12108-9.
72. Hadimani SB, Tanpure RP, Bhat SV. Asymmetric Total Synthesis of (-)-Podophyllotoxin. Tetrahedron Lett 1996; 37: 4791-4.
73. Bush EJ, Jones DW. Asymmetric total synthesis of (-)-podophyllotoxin. J Chem Soc Chem Commun 1993; 1200-1201.
74. Stadler D, Bach T. Concise Stereoselective Synthesis of (-)-Podophyllotoxin by an Intermolecular Iron(III)-Catalyzed Friedel-Crafts Alkylation. Angew Chem Int Ed 2008; 47: 7557-9.
75. Meyers AI, Barner B, Roth G, Hoyer D, Laucher D. Asymmetric Tandem Addition to Chiral 1-and 2-Substituted Naphthalenes. Application to the Synthesis of (+)-Phyltetralin. J Am Chem Soc 1988; 110: 4611-24.
76. Berkowitz D. Ring E-modified analogues of (-)-podophyllotoxin and etoposide and a method for their synthesis. US6051721, 2000.
77. Kaneko T, Wong HSL. Process for the preparation of podophyllotoxin. US5106996, 1992.